Experimental design
The dogs were divided into two groups, group MBO
contains fifty dogs, were treated with milbemycin oxime
(2 mg/kg bodyweight) orally, and applied weeklyfor continually three weeks, group vehicle consisting
of fifteen dogs, were treated with vehicle.